Table 5.
GAD-7 | Cohort 1b (2018–2019) | Cohort 2c (2019–2020) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
ΔR2 | β | s.e. β | Standardised β | P-value | ΔR2 | β | s.e. β | Standardised β | P-value | |
Control variables | 0.32 | 0.42 | ||||||||
Constant | 0.86 | 0.11 | <0.001 | 0.90 | 0.12 | <0.001 | ||||
Female | 0.24 | 0.06 | 0.09* | <0.001 | 0.22 | 0.07 | 0.09* | <0.01 | ||
Lifetime anxiety disorderd | 0.37 | 0.07 | 0.11* | <0.001 | 0.39 | 0.08 | 0.14* | <0.001 | ||
Baseline anxietye | 0.52 | 0.02 | 0.49 | <0.001 | 0.53 | 0.03 | 0.55* | <0.001 | ||
Adjusted model | 0.04 | 0.04 | ||||||||
Constant | 1.40 | 0.25 | <0.001 | 0.27 | 0.30 | 0.37 | ||||
Female | 0.21 | 0.06 | 0.08* | <0.001 | 0.18 | 0.07 | 0.07* | 0.01 | ||
Lifetime anxiety disorderd | 0.25 | 0.07 | 0.08* | <0.001 | 0.30 | 0.07 | 0.11* | <0.001 | ||
Baseline anxietye | 0.35 | 0.03 | 0.33 | <0.001 | 0.37 | 0.03 | 0.38* | <0.001 | ||
Locus of control | ||||||||||
Internalf | −0.01 | 0.01 | −0.01 | 0.63 | – | – | – | – | ||
Externalf | 0.02 | 0.01 | 0.08* | <0.01 | – | – | – | – | ||
Perfectionism | ||||||||||
Personal standardsg | – | – | – | – | 0.04 | 0.01 | 0.10* | <0.001 | ||
Evaluative concernsg | – | – | – | – | 0.04 | 0.02 | 0.09* | 0.01 | ||
Self-esteemh | −0.03 | 0.01 | −0.11* | <0.001 | −0.01 | 0.01 | −0.07 | 0.06 | ||
Baseline insomniai | 0.03 | <0.01 | 0.16* | <0.001 | 0.02 | <0.01 | 0.14* | <0.001 | ||
Adjusted R2 for final model | 0.37 | 0.46 |
GAD-7, Generalised Anxiety Disorder-7.
Continuous value measured by the GAD-7 at follow-up, then square-root adjusted.
P < 0.05.
Student-reported at entry to university.
Measured by the GAD-7 at entry.
Measured by the German Socio-Economic Panel locus of control subscale at entry. No data available for Cohort 2.
Measured by the Clinical Perfectionism Questionnaire subscale at entry. No data available for Cohort 1.
Measured by the Rosenberg Self-Esteem Scale at entry.
Measured by the Sleep Condition Indicator, reverse-coded at entry.
P < 0.05.